Analyst Price Targets — DTM
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 26, 2026 6:03 am | Keith Stanley | Wolfe Research | $145.00 | $126.74 | StreetInsider | Wolfe Research Upgrades DT Midstream (DTM) to Outperform |
| July 31, 2026 8:27 am | — | Jefferies | $155.00 | $136.77 | TheFly | DT Midstream price target lowered to $155 from $170 at Jefferies |
| July 16, 2026 11:26 am | — | Jefferies | $170.00 | $145.29 | TheFly | DT Midstream price target raised to $170 from $164 at Jefferies |
| July 8, 2026 2:29 pm | Julien Dumoulin-Smith | Jefferies | $164.00 | $146.72 | TheFly | DT Midstream price target lowered to $164 from $166 at Jefferies |
| May 26, 2026 10:44 am | — | Scotiabank | $176.00 | $151.12 | TheFly | DT Midstream initiated with an Outperform at Scotiabank |
| May 12, 2026 12:28 pm | Robert Kad | Morgan Stanley | $170.00 | $144.44 | TheFly | DT Midstream price target raised to $170 from $165 at Morgan Stanley |
| May 1, 2026 10:11 am | Julien Dumoulin-Smith | Jefferies | $166.00 | $147.99 | TheFly | DT Midstream price target raised to $166 from $150 at Jefferies |
| May 1, 2026 9:24 am | — | Barclays | $143.00 | $147.99 | TheFly | DT Midstream price target raised to $143 from $141 at Barclays |
| April 30, 2026 7:07 pm | — | Raymond James | $158.00 | $147.99 | TheFly | DT Midstream price target raised to $158 from $145 at Raymond James |
| April 20, 2026 10:15 am | — | Goldman Sachs | $127.00 | $134.24 | TheFly | DT Midstream price target raised to $127 from $111 at Goldman Sachs |
Latest News for DTM
As noted last week, midstream MLPs and corporations broadly raised full-year financial guidance following a strong second quarter. Looking ahead, the sector's growth runway is accelerating.
Wall Street analysts are reshuffling their bets ahead of a critical inflation report and NVIDIA earnings that could jolt markets in either direction. Find out which names got upgraded, cut, or newly covered before the opening bell Wednesday.
Investors need to pay close attention to DTM stock based on the movements in the options market lately.
DT Midstream commands a premium valuation due to its shift from gathering to pipeline-focused natural gas infrastructure with dual demand engines: LNG/industrial and utility/data center end markets. DTM's $3.4 billion brownfield project backlog, with 5x–8x build multiples, underpins visible EBITDA growth and justifies the premium versus sector peers trading at lower multiples. Robust dividend coverage (2.3x–2.5x),…
West Pharmaceuticals stock moved higher following another quarter of broad-based growth, driven by continued demand for high-value biologics packaging and proprietary delivery components. Tyler Technologies underperformed during the quarter despite delivering solid financial results that met management's guidance. We were attracted to Knowles' accelerating organic growth, expanding margins, and exposure to several…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for DTM.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.